Ginkgo Bioworks (NYSE: DNA) today announced the official launch of Ginkgo Cloud Lab. This new interface allows researchers to ...

The average one-year price target for Ginkgo Bioworks Holdings (NYSE:DNA) has been revised to $10.88 / share. This is a decrease of 11.11% from the prior estimate of $12.24 dated November 7, 2025. The ...

Why Ginkgo Bioworks is back on investors’ radar Ginkgo Bioworks Holdings (DNA) has drawn fresh attention after reporting full ...

Ginkgo Bioworks Holdings, Inc. (DNA) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

Ginkgo Bioworks Holdings, Inc. (DNA) shares rallied 18.9% in the last trading session to close at $11.25. This move can be attributable to notable volume with a higher number of shares being traded ...

The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and symbol volume. Created with Highcharts 12.5.0 ...

Ginkgo Bioworks continues to face a challenging demand environment, with the company's exposure to the U.S. government spending a potential vulnerability. Cost-cutting efforts have led to lower cash ...

Ginkgo Bioworks Holdings (NYSE: DNA) shares are trading higher Monday afternoon, up over 8%, following the announcement of a strategic partnership with Carnegie Mellon University under the Advanced ...

We recently published an article titled Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc.